Elevidys Is a One-Time Gene Therapy for Duchenne Muscular Dystrophy (DMD)

Elevidys (Delandistrogene Moxeparvovec-rokl) is a one-time gene therapy that delivers a shortened form of the dystrophin protein to muscle cells in children with Duchenne muscular dystrophy (DMD), a rare and progressive genetic disease that causes muscles to weaken and break down over time.

If your child has been diagnosed with DMD, understanding what Elevidys is, how it works, who qualifies, and what it costs is essential for making informed treatment decisions. This guide covers everything you need to know about Elevidys in 2026.

What Is Elevidys?

Here are the key facts about Elevidys:

• Brand name: Elevidys
• Generic name: Delandistrogene Moxeparvovec-rokl (also known as SRP-9001)
• Drug class: AAV vector-based gene therapy (adeno-associated virus serotype rh74)
• Manufacturer: Sarepta Therapeutics
• FDA approval: Initially granted accelerated approval for broader DMD population; later restricted to ambulatory patients aged 4 and older following safety concerns
• Controlled substance: No — Elevidys is not a controlled substance
• Dosage form: Intravenous infusion suspension, supplied in weight-based kits

Elevidys uses an AAVrh74 viral vector — essentially a harmless virus shell — to deliver a gene that produces a shortened but functional version of dystrophin called micro-dystrophin. This protein helps stabilize muscle cell membranes, partially compensating for the full-length dystrophin that DMD patients cannot produce. Learn more about how Elevidys works at the cellular level.

What Is Elevidys Used For?

Elevidys is approved for the treatment of Duchenne muscular dystrophy (DMD) in patients who meet all of the following criteria:

• Ambulatory — The patient must still be able to walk. The FDA withdrew the non-ambulatory indication in late 2025 after reports of fatal liver injury.
• Age 4 or older — Not approved for children under 4.
• Confirmed DMD gene mutation — Genetic testing must confirm a mutation in the DMD gene that is amenable to treatment with Elevidys.
• No deletions affecting exons 8 or 9 — Patients with these specific deletions are excluded from treatment.

DMD primarily affects boys, with symptoms typically appearing between ages 2 and 5. The disease progressively weakens skeletal and cardiac muscle, eventually affecting the ability to walk, breathe, and sustain heart function. Elevidys aims to slow this progression by providing muscle cells with a functional dystrophin protein.

How Is Elevidys Taken?

Elevidys is not a pill, injection, or inhaler. It is a one-time intravenous (IV) infusion administered at a specialized treatment center. Here's what the treatment process looks like:

1. Pre-treatment preparation — Your child begins a corticosteroid regimen the day before infusion. Baseline blood work, liver function tests, and cardiac assessments are completed.
2. Infusion day — The Elevidys infusion takes approximately 1–2 hours using a syringe infusion pump with an in-line 0.2-micron filter. It is administered by trained healthcare professionals at an authorized treatment center.
3. Post-infusion monitoring — Your child will be monitored closely at the treatment center and then through regular follow-up visits. Corticosteroids must continue for at least 60 days after infusion.
4. Ongoing lab monitoring — Liver function, platelet counts, and cardiac markers (Troponin-I) are checked frequently in the weeks and months after treatment.

The 21.5–22.4 Kg kit is one of many weight-band kits available. Your child's dose is determined by their weight, with the standard dose being 1.33 × 10¹⁴ vg/kg for patients under 70 kg.

Who Should Not Take Elevidys?

Elevidys is contraindicated (should not be given) in the following situations:

• DMD gene deletions affecting exons 8 or 9 — The micro-dystrophin construct does not address these mutations.
• Preexisting liver impairment — Given the Boxed Warning for fatal liver injury, patients with existing liver problems cannot receive Elevidys.
• Recent vaccinations — Live vaccines should be completed well before treatment, as the immunosuppressive regimen required after Elevidys makes live vaccines dangerous.
• Recent or active infections — Treatment must be delayed until infections are fully resolved.
• Non-ambulatory patients — The FDA restricted the indication to ambulatory patients only following fatal adverse events. Read more about why this change happened.

How Much Does Elevidys Cost?

Elevidys has a wholesale acquisition cost of approximately $3.2 million for the one-time treatment. This makes it one of the most expensive medications in the world.

Key cost facts:

• No generic available — Elevidys is a biologic gene therapy with no biosimilar alternative.
• Insurance coverage — Most commercial and government payers require extensive prior authorization, including genetic confirmation, ambulatory status documentation, and specialist letters of medical necessity.
• Manufacturer support — SareptAssist (1-888-727-3782) helps families navigate insurance coverage, prior authorization, appeals, and financial assistance. Learn more about financial assistance options for Elevidys.

Because Elevidys is a one-time treatment, the cost is not recurring like monthly medications. However, the upfront cost creates significant insurance and access challenges that SareptAssist is designed to help navigate.

Side Effects at a Glance

Common side effects include vomiting, nausea, fever, elevated liver enzymes, low platelet counts, and elevated Troponin-I. Serious risks include acute liver failure (Boxed Warning), myocarditis, blood clots, and severe infections. For a complete breakdown, read our detailed guide on Elevidys side effects.

Final Thoughts

Elevidys represents a major advance in DMD treatment — a single infusion that delivers a functional dystrophin protein to muscle cells. But it's also a complex, expensive, and high-risk therapy that requires careful patient selection, specialized treatment centers, and intensive post-treatment monitoring.

If you're exploring Elevidys for your child, start by connecting with a neuromuscular specialist who prescribes Elevidys, contact SareptAssist for support, and use Medfinder to check availability and find treatment centers near you.